Valganciclovir in Prevention of Cytomegalovirus (CMV) Reactivation Following Allogeneic-Stem Cell Transplantation (SCT)

Clinical trial NCT00330018 · COMPLETED

Trial details

NCT number: NCT00330018
Sponsor: Hadassah Medical Organization
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Bone Marrow Transplantation Cytomegalovirus

Start date: 2006-02-01
Primary completion: 2010-04-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.